Swiss Re AG
F:SR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
F:SR9
|
CH |
|
Cytek Biosciences Inc
F:8EQ
|
US |
Intrinsic Value
The intrinsic value for
Swiss Re AG (SR9) under the Base Case is 152.64 EUR.
Compared with the current market price of 148.45 EUR, the stock appears
Undervalued by 3% .
Do our valuations actually work? See backtest results .
The intrinsic value for
Swiss Re AG (SR9) under the Base Case is 152.64 EUR.
Compared with the current market price of 148.45 EUR, the stock appears Undervalued by 3% .